Minimizing Patient Burden Through the Use of Historical Subject-Level Data in Innovative Confirmatory Clinical Trials: Review of Methods and Opportunities-Reference-Cited by-同舟云学术

Minimizing Patient Burden Through the Use of Historical Subject-Level Data in Innovative Confirmatory Clinical Trials: Review of Methods and Opportunities

Published:2018-09 Issue:5 Volume:52 Page:546-559
ISSN:2168-4790
Container-title:Therapeutic Innovation & Regulatory Science
language:en
Short-container-title:Ther Innov Regul Sci

Author:

Lim Jessica,Walley Rosalind,Yuan Jiacheng,Liu Jeen,Dabral Abhishek,Best Nicky,Grieve Andrew,Hampson Lisa,Wolfram Josephine,Woodward Phil,Yong Florence,Zhang Xiang,Bowen Ed

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1177/2168479018778282.pdf

Reference94 articles.

1. Food and Drug Administration (FDA). Innovation or Stagnation: Challenge and Opportunity on the Critical Path to New Medical Products. Rockville, MD: FDA; 2004.

2. Watson JL, Ryan L, Silverberg N, Cahan V, Bernard MA. Obstacles and opportunities in Alzheimer’s clinical trial recruitment. Health Affairs (Millwood). 2014;33:574–579.

3. ClinicalTrials.gov Web site. https://clinicaltrials.gov/ Accessed July 24, 2017.

4. Higgins JPT, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343: d5928.

5. Pocock SJ. The combination of randomized and historical controls in clinical trials. J Chronic Dis. 1976;29:175–188.

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing External Control Arm Analyses through Data Calibration and Hybrid Designs;Clinical Pharmacology & Therapeutics;2024-07-02

2. Do You Want to Stay Single? Considerations on Single‐Arm Trials in Drug Development and the Postregulatory Space;Pharmaceutical Statistics;2024-06-25

3. Propensity score weighted multi‐source exchangeability models for incorporating external control data in randomized clinical trials;Statistics in Medicine;2024-06-24

4. Beyond the Classical Type I Error: Bayesian Metrics for Bayesian Designs Using Informative Priors;Statistics in Biopharmaceutical Research;2024-05-31

5. Augmenting external control arms using Bayesian borrowing: a case study in first-line non-small cell lung cancer;Journal of Comparative Effectiveness Research;2024-05